Next Generation News and Research

RSS

Oxford Gene Technology launches Cytocell FISH probe for bladder cancer

Oxford Gene Technology (OGT), The Molecular Genetics Company, has launched its CE-IVD labelled Cytocell Aquarius® P16/3c/7c/17c Probe Kit, a cost-effective, ready-to-use fluorescence in situ hybridisation (FISH) probe kit for non-invasive detection of bladder cancer — for sale in Europe.

From Oxford Gene Technology 6 Oct 2015

Epilepsy Society becomes third customer of Complete Genomics' newly introduced Revolocity system

Complete Genomics, Inc., a leader in whole human genome sequencing, announced today that leading UK charity Epilepsy Society has become the third customer of the company's newly introduced Revolocity system, a supersequencer for large-scale, high-quality whole genome and whole exome sequencing.

6 Oct 2015

Paradigm failure is primary reason for lack of progress in cancer research, says cancer biologist

A recent publication, which received sustained media attention, claimed that most cancers are just “bad luck”. Its authors stated that only about one-third of cancer mutations are caused by known lifestyle or environmental factors.

6 Oct 2015

Early genetic diagnosis in neonatal diabetes a ‘new framework for clinical care’

Early genetic testing of babies with suspected neonatal diabetes identifies the underlying cause in more than 80% of cases, say researchers.

1 Oct 2015

GENALICE announces global launch date of new analysis module for genomics researchers

Today GENALICE announced the global launch date of Population Calling, a new analysis module and part of their GENALICE MAP Next-Generation Sequencing Data Analysis Suite.

29 Sep 2015

Creating a new paradigm for management of yeast infections

Yeasts are unicellular microorganisms classified within the Fungi kingdom. They are well known for their use in baking, winemaking and beer brewing fermentation, but some species of yeast are opportunistic pathogens that can cause infections in humans. "Today, yeast infections are poorly understood, difficult to diagnose, and are becoming increasingly frequent and serious, affecting over 300 million people worldwide.

26 Sep 2015

Scientists compile complete genetic information of people affected by PAH

The genetic architecture of a debilitating and potentially fatal vascular disease has for the first time been detailed in its entirety, providing clinicians with the comprehensive data needed to improve diagnosis and deliver more personalised patient care.

25 Sep 2015

Brain & Behavior Research Foundation announces recipients of NARSAD Young Investigator Grants

The Brain & Behavior Research Foundation today announced the award of its NARSAD Young Investigator Grants valued at more than $13 million to 191 of the world's most promising young scientists.

24 Sep 2015

Johns Hopkins scientists discover earliest premalignant genetic changes that mark potential onset of lung cancer

Working with tissue, blood and DNA from six people with precancerous and cancerous lung lesions, a team of Johns Hopkins scientists has identified what it believes are among the very earliest “premalignant” genetic changes that mark the potential onset of the most common and deadliest form of disease.

23 Sep 2015

Novel nebuliser could one day deliver life-saving cancer drugs

A revolutionary nebuliser developed by RMIT University researchers could one day deliver life-saving cancer drugs and vaccines traditionally given by injection.

21 Sep 2015

New study finds link between maternal protein deficiency during pregnancy and metabolic diseases in offspring

A new study has uncovered the genetic processes that link insufficient protein consumption during pregnancy with the development of muscle problems in mothers and their male offspring.

19 Sep 2015

Thomas Jefferson University provides routine genomic fingerprinting to cancer patients

Cancer medicine is moving towards understanding what drives each particular patient's cancer. But not every patient has had access to this level of individualized care.

18 Sep 2015

UCPH, Beckman Coulter Genomics identify effects of cancer on protein signaling networks within human cells

Studies published of early results of the strategic collaboration between Beckman Coulter Genomics and Linding Lab at UCPH.

From Beckman Coulter Life Sciences - Automation and Genomics 18 Sep 2015

Advances in rehabilitation devices improve quality of life for impaired patients, finds Frost & Sullivan

In today’s increasingly independent and active lifestyle, patients with physical impairment due to age or a strokefeel the need for improved devices capable of helping them lead a quality life.

18 Sep 2015

Bioquell to unveil advanced pathogen eradication technology at annual IPS conference

Antibiotic-resistant pathogens such as CPE and hospital-acquired infections like C.difficile or norovirus seem to be relentlessly lurking around NHS hospitals.

16 Sep 2015

New whitepaper describes benefits of using OGT’s CytoSure Medical Research Exome Array in genetic research

Oxford Gene Technology, The Molecular Genetics Company, has been speaking to genetic scientists, Dr Tracey Lewis (Associated Regional and University Pathologists Laboratories) and Dr Emily Farrow (Children’s Mercy Hospital), in a new whitepaper entitled “Examining the Medical Exome”.

From Oxford Gene Technology 15 Sep 2015

BfArM approves Greenovation’s moss-aGal phase I clinical trial for Fabry disease

Greenovation Biotech GmbH announced today that it has received approval to begin a phase I clinical trial in Europe for its first drug candidate moss-aGal (agalsidase) from Germany's regulatory authority, the Federal Institute for Drugs and Medical Devices (BfArM).

15 Sep 2015

All Children's Hospital Johns Hopkins Medicine receives first national grant to train medical residents

All Children's Hospital Johns Hopkins Medicine just received its first national grant from the The Hearst Foundations for $100,000. The grant will help fund the exclusive Leadership Executive Academic Development (LEAD) curriculum provided to medical residents in All Children's Hospital Johns Hopkins Medicine pediatric residency program. LEAD is a two-week program focused on transforming the residents from pediatric physicians to pediatric physician leaders.

15 Sep 2015

Cancer Research UK introduces three new funding schemes to support careers of cancer doctors

Cancer Research UK is launching three new funding schemes to support the careers of cancer doctors researching new ways to prevent, diagnose and treat the disease.

15 Sep 2015

ProPhase partners with Multi Health Systems to standardize electronic adaptations of PANSS

ProPhase LLC, a global provider of applied measurement expertise, is announcing its partnership with Multi Health Systems, a Canadian publisher of psychological assessments and healthcare outcomes, to optimize and standardize electronic adaptations of the Positive and Negative Syndrome Scale (PANSS).

14 Sep 2015

Next Generation News and Research

Oxford Gene Technology launches Cytocell FISH probe for bladder cancer

Epilepsy Society becomes third customer of Complete Genomics' newly introduced Revolocity system

Paradigm failure is primary reason for lack of progress in cancer research, says cancer biologist

Early genetic diagnosis in neonatal diabetes a ‘new framework for clinical care’

GENALICE announces global launch date of new analysis module for genomics researchers

Creating a new paradigm for management of yeast infections

Scientists compile complete genetic information of people affected by PAH

Brain & Behavior Research Foundation announces recipients of NARSAD Young Investigator Grants

Johns Hopkins scientists discover earliest premalignant genetic changes that mark potential onset of lung cancer

Novel nebuliser could one day deliver life-saving cancer drugs

New study finds link between maternal protein deficiency during pregnancy and metabolic diseases in offspring

Thomas Jefferson University provides routine genomic fingerprinting to cancer patients

UCPH, Beckman Coulter Genomics identify effects of cancer on protein signaling networks within human cells

Advances in rehabilitation devices improve quality of life for impaired patients, finds Frost & Sullivan

Bioquell to unveil advanced pathogen eradication technology at annual IPS conference

New whitepaper describes benefits of using OGT’s CytoSure Medical Research Exome Array in genetic research

BfArM approves Greenovation’s moss-aGal phase I clinical trial for Fabry disease

All Children's Hospital Johns Hopkins Medicine receives first national grant to train medical residents

Cancer Research UK introduces three new funding schemes to support careers of cancer doctors

ProPhase partners with Multi Health Systems to standardize electronic adaptations of PANSS

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News